DeNovX is ...
an innovative pharmaceutical technology company that provides platform products and services to the pharmaceutical, nutraceutical and cosmeceutical industries. Our fine chemicals division produces our flagship product; a 100% pure crystalline epigallocatechin gallate (EGCg) from green tea produced utilizing a patented, proprietary process. Our pharmaceutical technology division is focused on the commercialization of products to accelerate pharmaceutical and nutraceutical development while creating new intellectual property (IP) for commercially relevant products.
EGCg is principally responsible for the health benefits associated with green tea. Our crystalline EGCg gives a product that is natural, consistently 100% pure and possessing crystals that are of a narrow size distribution. Users of our crystalline EGCg can rest assured that they are using the finest quality EGCg available anywhere.
Over 90% of active pharmaceutical ingredients (APIs) are crystalline solids, and our crystal development technologies reduce the risks associated with controlling the size, shape, and structure of these high value materials while creating new IP to enhance competitive advantage and to extend product life cycles.
Think Forward - to pure crystalline EGCg, rational crystal screening and solid form controls.